Arterys Receives First FDA Clearance for Broad Oncology Imaging Suite with Deep Learning
FDA clearance covers all solid tumors. Initial launch will include Liver AI and Lung AI oncology software to empower clinicians to quickly measure and track lesions and nodules in MRI and CT scans
SAN FRANCISCO, Feb. 15, 2018 -- (Healthcare Sales & Mark... Devices, Radiology, Oncology, FDA Arterys, imaging, artificial intelligence
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | CT Scan | Learning | Liver | Liver Transplant | Lung Transplant | PET Scan | Pharmaceuticals | Radiology | Universities & Medical Training | Urology & Nephrology